Cargando…

A Rare Culprit of Methemoglobinemia

Methemoglobinemia is a rare cause of hypoxia and can be a diagnostic challenge early in the disease course. The incidence of medication-induced methemoglobinemia is more common than congenital-related methemoglobinemia. The most common cause of methemoglobinemia is exposure to household detergents,...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadah, Kahtan, Rivera, Miguel, Lingireddy, Ajay, Kalas, M. Ammar, Ghafouri, Reshad S., Deoker, Abhizith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379961/
https://www.ncbi.nlm.nih.gov/pubmed/35959982
http://dx.doi.org/10.1177/23247096221117919
_version_ 1784768780127174656
author Fadah, Kahtan
Rivera, Miguel
Lingireddy, Ajay
Kalas, M. Ammar
Ghafouri, Reshad S.
Deoker, Abhizith
author_facet Fadah, Kahtan
Rivera, Miguel
Lingireddy, Ajay
Kalas, M. Ammar
Ghafouri, Reshad S.
Deoker, Abhizith
author_sort Fadah, Kahtan
collection PubMed
description Methemoglobinemia is a rare cause of hypoxia and can be a diagnostic challenge early in the disease course. The incidence of medication-induced methemoglobinemia is more common than congenital-related methemoglobinemia. The most common cause of methemoglobinemia is exposure to household detergents, illicit drugs, or medications with nitrate or sulfonamide chemical groups. The 2 main medications accounting for up to 45% of medication-induced cases are dapsone and benzocaine. We report a case of hypoxia and diarrhea with an arterial blood gas (ABG) showing methemoglobinemia at 26%. Infectious and autoimmune workup were negative. Methemoglobinemia level returned to normal level within 2 weeks of hydrochlorothiazide discontinuation, suggesting medication-induced methemoglobinemia at appropriate hypertension dosage. In this case, there was an acute rise in methemoglobin levels following initiation of an hydrochlorothiazide-losartan combination, which improved following the discontinuation of hydrochlorothiazide. Extensive workup ruled out cytochrome b5 reductase (Cb5R) and Glucose-6-phosphate dehydrogenase (G6PD) deficiency, which raised the suspicion of hydrochlorothiazide-induced methemoglobinemia, as it is part of the sulfa drug family.
format Online
Article
Text
id pubmed-9379961
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-93799612022-08-17 A Rare Culprit of Methemoglobinemia Fadah, Kahtan Rivera, Miguel Lingireddy, Ajay Kalas, M. Ammar Ghafouri, Reshad S. Deoker, Abhizith J Investig Med High Impact Case Rep Case Report Methemoglobinemia is a rare cause of hypoxia and can be a diagnostic challenge early in the disease course. The incidence of medication-induced methemoglobinemia is more common than congenital-related methemoglobinemia. The most common cause of methemoglobinemia is exposure to household detergents, illicit drugs, or medications with nitrate or sulfonamide chemical groups. The 2 main medications accounting for up to 45% of medication-induced cases are dapsone and benzocaine. We report a case of hypoxia and diarrhea with an arterial blood gas (ABG) showing methemoglobinemia at 26%. Infectious and autoimmune workup were negative. Methemoglobinemia level returned to normal level within 2 weeks of hydrochlorothiazide discontinuation, suggesting medication-induced methemoglobinemia at appropriate hypertension dosage. In this case, there was an acute rise in methemoglobin levels following initiation of an hydrochlorothiazide-losartan combination, which improved following the discontinuation of hydrochlorothiazide. Extensive workup ruled out cytochrome b5 reductase (Cb5R) and Glucose-6-phosphate dehydrogenase (G6PD) deficiency, which raised the suspicion of hydrochlorothiazide-induced methemoglobinemia, as it is part of the sulfa drug family. SAGE Publications 2022-08-12 /pmc/articles/PMC9379961/ /pubmed/35959982 http://dx.doi.org/10.1177/23247096221117919 Text en © 2022 American Federation for Medical Research https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Fadah, Kahtan
Rivera, Miguel
Lingireddy, Ajay
Kalas, M. Ammar
Ghafouri, Reshad S.
Deoker, Abhizith
A Rare Culprit of Methemoglobinemia
title A Rare Culprit of Methemoglobinemia
title_full A Rare Culprit of Methemoglobinemia
title_fullStr A Rare Culprit of Methemoglobinemia
title_full_unstemmed A Rare Culprit of Methemoglobinemia
title_short A Rare Culprit of Methemoglobinemia
title_sort rare culprit of methemoglobinemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379961/
https://www.ncbi.nlm.nih.gov/pubmed/35959982
http://dx.doi.org/10.1177/23247096221117919
work_keys_str_mv AT fadahkahtan arareculpritofmethemoglobinemia
AT riveramiguel arareculpritofmethemoglobinemia
AT lingireddyajay arareculpritofmethemoglobinemia
AT kalasmammar arareculpritofmethemoglobinemia
AT ghafourireshads arareculpritofmethemoglobinemia
AT deokerabhizith arareculpritofmethemoglobinemia
AT fadahkahtan rareculpritofmethemoglobinemia
AT riveramiguel rareculpritofmethemoglobinemia
AT lingireddyajay rareculpritofmethemoglobinemia
AT kalasmammar rareculpritofmethemoglobinemia
AT ghafourireshads rareculpritofmethemoglobinemia
AT deokerabhizith rareculpritofmethemoglobinemia